Influence of Expert-Dependent Variability over the Performance of Noninvasive Fibrosis Assessment in Patients with Chronic Hepatitis C by Means of Texture Analysis
Table 1
Characteristics of the study group.
Characteristics of patients
Entire lot
Patients with fibrosis stage 0
Patients with cirrhosis
Mean ± SD (interval or %)
Number
125 (100%)
51 (40.8%)
74 (59.2%)
Sex (male)
50 (40%)
16 (31.4%)
34 (45.9%)
Age (years)
(22–77)
(33–77)
(22–66)
BMI (kg/m2)
(18.56–46.48)
(18.83–46.48)
(18.56–33.87)
AST (U/I)
(12–387)
(23–387)
(12–71)
ALT (U/I)
(8–270)
(21–270)
(8–163)
GGT (U/I)
(13–993)
(27–993)
(13–130)
Total bilirubin (mg/dL)
(0.27–4.27)
(0.4–4.27)
(0.27–1.72)
Alkaline phosphatase (U/I)
(127–1781)
(127–1781)
(142–307)
Glucose (mg/dL)
(72–266)
(72–266)
(72–129)
Cholesterol (mg/dL)
(97–331)
(97–299)
(149–331)
Triglycerides (mg/dL)
(51–349)
(53–316)
(51–349)
Platelet count (109/L)
(42–373)
(42–373)
(151–314)
INR
(0.83–1.84)
(0.89–1.84)
(0.83–1.3)
Right lobe images per patient
(2–33)
(3–24)
(2–33)
Abbreviations: body mass index (BMI), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl-transpeptidase (GGT), and international normalized ratio (INR).
